Rizatriptan (Maxalt) is used to treat migraines with or without aura in people ages 6 years and older. Rizatriptan (Maxalt) is available as a lower-cost generic tablet and an orally disintegrating tablet (ODT) that's placed on the tongue. Common side effects include dizziness, headache, and sleepiness. It can interact with antidepressants and other similar migraine medications.
Treatment of migraine attacks with or without aura in people ages 6 years and older
Rizatriptan (Maxalt) is a triptan. It works to relieve migraines by attaching to and turning on serotonin receptors in the blood vessels and nerves in your brain. This causes the blood vessels to tighten and lowers the release of proteins that cause inflammation and pain.
Source:Â DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
heaviness, tightness, or pressure in the chest and/or neck
pounding heartbeat
sensation of burning, warmth, heat, numbness, tightness, or tingling
shortness of breath
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Dizziness
lack or loss of strength
nausea or vomiting
sleepiness or unusual drowsiness
unusual tiredness or weakness
Less common
Agitation
blurred vision
chills
confusion
difficulty with swallowing
feeling of constant movement of self or surroundings
headache
heat sensitivity
inability to sleep
increased sweating
increased thirst
irritability
itching of the skin
muscle or joint stiffness, tightness, or rigidity
muscle pain or spasms
ringing or buzzing in the ears
sudden, large increase in the frequency or quantity of urine
trembling of the hands or feet
unusual feeling of well-being
warm or cold sensations
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
First-choice option for treating migraines
Can be used by children ages 6 years and older
Orally disintegrating tablet (ODT) a possible option for people who have problems swallowing
Works within 30 minutes
Can't use to prevent migraines
Is short-acting, so it might not last as long
Not clear if taking a second dose (adults only) is actually helpful
Your migraines can get worse if you use this medication too often.
You can take rizatriptan (Maxalt) with or without food. If it's hurting your stomach, try taking it with food to help.
Rizatriptan (Maxalt) isn't meant to be used to treat more than 4 migraines per month because it might not be safe to do so. If you have migraines multiple times a month, let your provider know. They can consider other medication options to help with your symptoms. Or they can let you know if you need to start any medications for migraine prevention.
Rizatriptan (Maxalt) interacts with many medications. Depending on the situation, your provider might have to adjust your dose of rizatriptan (Maxalt) or the other medication that you're taking. Make sure to let your provider and pharmacist know about all the medications you're taking (including vitamins and supplements) before starting rizatriptan (Maxalt) so that they can help you check for interactions. If there are many interactions, your provider might even switch you to a different migraine medication.
Rizatriptan (Maxalt) can make you feel very sleepy or dizzy. Don't drive or do anything that requires a lot of attention until you know how this medication affects you.
You might feel tightness, pressure, or pain in the chest, throat, jaw, or neck after taking rizatriptan (Maxalt). This usually doesn't last long and will go away. However, these symptoms are very similar to symptoms of a heart attack or heart problems. If you notice that these symptoms are worsening or don't go away, get medical help right away.
If you're using the dissolvable tablet, make sure your hands are dry before handling the medication. Peel off the foil backing, and remove the tablet from the blister card. Don't try to push the tablet through the foil; this can damage the medication. Place the tablet on the tongue to let it dissolve, and swallow with saliva. You don't need to drink anything.
Rizatriptan (Maxalt) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: History of heart problems | People ages older than 65 | Diabetes | People who identify as obese | High blood pressure | Smoking tobacco
Although rare, some people have reported serious heart problems, such as heart attack and heart rhythm problems, within a few hours after taking rizatriptan (Maxalt). In addition, rizatriptan (Maxalt) can raise your blood pressure, rarely to dangerously high levels. If you have a history of heart or blood vessel problems, talk to your provider first to make sure rizatriptan (Maxalt) is as safe for you as possible. Make sure to check your blood pressure periodically while you're taking rizatriptan (Maxalt), and let your provider know if it's higher than usual. Get emergency help right away if you experience a heart attack, severe headache, chest pain, or irregular heartbeat.
Some people who've taken triptans like rizatriptan (Maxalt) have experienced life-threatening strokes or bleeding in the brain. Symptoms of such brain injury include sudden weakness on one side of the body, bad headaches, drooping face, trouble breathing, or changes in your speech or vision. These symptoms can be similar to migraine symptoms, so strokes can be mistaken for a migraine. Let your provider know if you've had a stroke in the past because you won't be able to take rizatriptan (Maxalt). If you notice symptoms of a stroke, stop taking rizatriptan (Maxalt) and get medical help as soon as possible, especially if you haven't had a migraine before.
Rizatriptan (Maxalt) can cause extreme narrowing of your blood vessels in different parts of your body. Depending on the location, this can lead to serious stomach problems (e.g., stomach pain, bloody diarrhea), vision problems, and changes in sensation of your hands and feet. It can also lead to color changes in your hands and feet (can turn pale or reddish depending on how much blood is flowing through). If you notice these symptoms after taking rizatriptan (Maxalt), don't take any more medication until you see a provider so they can check out what's going on.
Taking more than the recommended dose of migraine medications can cause them to not work as well. This can lead to more migraine-like headaches or more migraine attacks. If you're taking multiple migraine medications, let your provider know if you're taking them for more than 9 days per month. Also, let your provider know if you're experience more than 4 migraine headaches a month while taking rizatriptan (Maxalt). They can talk with you about better options to help with migraines.
Risk factors: Taking other medications that raise serotonin levels in your brain
Some people taking rizatriptan (Maxalt) have developed a rare, but potentially life-threatening condition called serotonin syndrome. This condition happens where there's too much serotonin in the brain. Your risk for serotonin syndrome goes up if you use rizatriptan (Maxalt) with other medications that can raise your serotonin levels, such as certain antidepressants, mental health medications, pain medications, and migraine medications.
Let your provider know about all the medications you take before starting rizatriptan (Maxalt), as well as any medications you plan to take. Symptoms of serotonin syndrome include fast heart rate, sweating, muscle stiffness or spasms, fever, and confusion. Get medical help right away if you have any of these symptoms.
The rizatriptan (Maxalt) orally disintegrating tablets (ODTs) contain phenylalanine, a component of the artificial sweetener aspartame. If you have a genetic condition called phenylketonuria (PKU), taking the ODTs can be dangerous for you. Let your provider know if you have PKU so they can prescribe a different formulation of rizatriptan (Maxalt) that might be safer for you.
Rizatriptan (Maxalt) is available as an oral tablet taken by mouth and as an orally disintegrating tablet (ODT) that's dissolved on the tongue.
Adults ages 18 years and older: The typical dose is 5 mg to 10 mg by mouth once when you have a migraine. If your migraine doesn't go away, you can take another dose at least 2 hours later. The maximum dose is 30 mg in a 24-hour period.
Children ages 6 to less than 18 years old: Your child's provider will determine the dose based on your child's body weight.
Weight less than 40 kg (88 lbs): The typical dose is 5 mg by mouth once when your child has a migraine. Don't take more than 5 mg in a 24-hour period.
Weight 40 kg (88 lbs) or more: The typical dose is 10 mg by mouth once when your child has a migraine. Don't take more than 10 mg in a 24-hour period.
Your dose might differ if you're also taking propranolol (Inderal).
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Coronary artery vasospasm (e.g., Prinzmetal's angina)
History of stroke or transient ischemic attack ("mini-stroke")
History of hemiplegic or basilar migraines (because of higher risk of stroke)
Uncontrolled high blood pressure
Use of ergot-containing or ergot-type medications like dihydroergotamine (Migranal) or other triptans in the last 24 hours
Currently take or have taken a monoamine oxidase inhibitor (MAOI), such as selegiline (Zelapar), in the last 14 days
Treatment of migraine attacks with or without aura in people ages 6 years and older
Treatment of migraine attacks with or without aura in adults
Treatment of migraine attacks with or without aura in adults
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Ailani, J., et al. (2021). The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache: The Journal of Head and Face Pain.
Breckenridge Pharmaceutical, Inc. (2020). RIZATRIPTAN BENZOATEÂ - rizatriptan benzoate tablet, orally disintegrating [package insert]. DailyMed.
Diener, H., et al. (2019). Treatment of migraine attacks and prevention of migraine: Guidelines by the German Migraine and Headache Society and the German Society of Neurology. Clinical and Translational Neuroscience.
Feuerstadt, P. (2019). Small Bowel Ischemia. American College of Gastroenterology.Â
Kadian, R., et al. (2023). Basilar Migraine. StatPearls.
Kolodny, A., et al. (2004). Comparison of Rizatriptan 5 mg and 10 mg Tablets and Sumatriptan 25 mg and 50 mg Tablets. Cephalalgia.
Kumar, A., et al. (2023). Hemiplegic Migraine. StatPearls.
Macleods Pharmaceuticals Limited. (2023). RIZATRIPTAN BENZOATE tablet, orally disintegrating [package insert]. DailyMed.
Marchenko, A., et al. (2015). Pregnancy Outcome Following Prenatal Exposure to Triptan Medications: A Meta-Analysis. Headache: The Journal of Head and Face Pain.
National Human Genome Institute. (2014). About phenylketonuria.
Nicolas, S., et al. (2023). Triptans. StatPearls.
Swarup, S., et al. (2023). Coronary Artery Vasospasm. StatPearls.
U.S. Department of Justice. (2020). Narcotics drug fact sheet.
Unichem Pharmaceuticals (USA), Inc. (2022). RIZATRIPTAN BENZOATE tablet [package insert]. DailyMed.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.